SunDoma^TM is a technology platform of the super high affinity antilbody developed by Longbio. The platform is developed based on the 30+ years' experience in hybridoma technology by the co-founder, Dr. Sun Nai-chau. Based on this platform, Longbio has developed a series of high affinity antibodies, including LP-003, the new generation of anti-IgE antibody.

Unique immune preparation
Unique immune approach

Hybridoma cells fusion
Single B cells

Multiple screening methods
Efficient to screen out target mab

Finish

High affinity antibody that developed by Sundoma^TM platform (KD)

(All KD data above are detected by KinExA)